CAS 1290628-31-7

AZ12216052

CAS: 1290628-31-7

AZ12216052

Formula: C₁₉H₂₂BrNOS

Purity: ≥98%

Molecular weight: 392.35

Ref: 54-BUP03302

AZ 12216052

CAS: 1290628-31-7

2-((4-Bromobenzyl)thio)-N-(4-(sec-butyl)phenyl)acetamide

Formula: C₁₉H₂₂BrNOS

Purity: 98%

Molecular weight: 392.35

Ref: IN-DG01437837

AZ 12216052

Controlled Product

CAS: 1290628-31-7

Formula: C₁₉H₂₂BrNOS

Color and Shape: Neat

Molecular weight: 392.353

Ref: TR-A808215

AZ 12216052

CAS: 1290628-31-7

AZ 12216052 is a selective allosteric modulator of the NMDA receptor that has shown antidepressant-like activity in whole-cell voltage-clamp studies. AZ 12216052 inhibits glutamate release by binding to and blocking the NMDA receptor, which prevents calcium influx into the postsynaptic neuron. It also has been found to have neuroprotective effects in an animal model of Huntington’s disease. The drug binds to NMDA receptors at a site different from that of ketamine, an anaesthetic and analgesic used as a rapid-onset antidepressant and pain reliever.

Formula: C₁₉H₂₂BrNOS

Purity: Min. 95%

Molecular weight: 392.35 g/mol

Ref: 3D-QBC62831

AZ12216052

CAS: 1290628-31-7

AZ12216052 is a GRP8 antagonist with anxiolytic and anti-inflammatory activity and can be used to study obesity and metabolic disorders.

Formula: C₁₉H₂₂BrNOS

Purity: 99.78%

Color and Shape: Solid

Molecular weight: 392.35

Ref: TM-T26701